Under the pathological conditions found in AMD or DMO, however, Ang2 acts as a competitive antagonist of Ang1, and inhibits the activation of the Tie-2 receptor, destabilising the retinal vasculature and making it more susceptible to the effects of pro-inflammatory cytokines and VEGF [36]. The gene discussed is VEGFA; the disease is age-related macular degeneration.